IP Library Assignment 025566/0330
Patent Assignment
Reel/Frame 025566/0330

Assignment of Assignor's Interest

Recorded: 2010-12-23 Pages: 4
Assignor
SHIRE BIOCHEM INC.
Executed: 2004-04-22
Assignee
VIROCHEM PHARMA INC.
275 ARMAND-FRAPPIER BLVD., LAVAL, QUEBEC, H7V 4A7, CANADA
Covered Property (1)
Compounds and Methods for the Treatment or Prevention of Flavivirus Infections
Patent: 7,985,769 →
Application: 11/042,442 →
Publication: US 2006/0142347
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger May 4, 2010
From: VIROCHEM PHARMA INC.
To: VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
Reel/Frame 024333/0387 →
Corrective Assignment to Correct the Assignee City of Corporation Previously Recorded on Reel 024333 Frame 0387. Assignor(S) Hereby Confirms the Merger. Oct 11, 2010
From: VIROCHEM PHARMA INC.
To: VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
Reel/Frame 025119/0863 →
Assignment of Assignor's Interest Dec 23, 2010
From: CHAN CHUN KONG, LAVAL; BEDARD, JEAN; DAS, SANJOY KUMAR; NGUYEN BA, NGHE
To: SHIRE BIOCHEM INC.
Reel/Frame 025566/0476 →
Change of Name Aug 13, 2013
From: PEREIRA, OSWY Z.
To: VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
Reel/Frame 030994/0793 →
Assignment of Assignor's Interest Aug 13, 2013
From: VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 030997/0434 →
Assignment of Assignor's Interest Oct 17, 2013
From: VERTEX PHARMACEUTICALS INCORPORATED
To: VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
Reel/Frame 031424/0361 →